The Changing Tide Toward Natural Medications

As awareness about the side effects of synthetic medicines is increasing, consumers are looking into natural medications that have fewer side effects. To meet this need, biopharmaceutical companies are developing innovative drugs through biotechnology that have fewer side effects but are just as effective as traditional medicines. Since biopharma companies have been snapping up the natural drug space, it looks like the traditional drug industry is feeling a little left out, with many big pharmaceutical companies leaping to merge with smaller biopharma firms to be able to use their research and create better cures.

This signifies great progress in the drug industry and hints toward a time when the pharmacy aisle in your local supermarket will display more natural medications than synthetic ones. This is also fantastic news for patients struggling with hard-to-treat diseases as these mega  mergers have the potential to discover new treatments that can help prolong lives. Scientists and doctors have already been deploying biotechnology to develop cures for diseases such as cancer, arthritis, and diabetes, and with more large-cap companies joining hands with biopharma firms, we can only expect new products that will help save more lives.

Some examples of biotechnology in action are immunotherapies and pharmacogenetics that have helped patients recover from various forms of cancers. Immunotherapies halt the growth of cancer cells by making the immune system stronger while pharmacogenetics is helping doctors create personalized cures based on a patient’s genes. There is also growing research in the field of hemp-derived cannabidiol (CBD) to create natural medicines that can help with acute pain, arthritis, epilepsy, and mental disorders. Even though CBD is associated with creating a “high” feeling that many try to avoid, biotechnology has found a way to derive it in a way that it has no intoxicating effects.

The discovery of CBD that does not cause addiction or a high feeling is a major milestone in the biopharmaceutical sphere. CBD has long been touted for its healing benefits but has also been stigmatized due to the “intoxicated” feeling that comes with it. The latest CBD treatments have a very low concentration of the high-inducing element tetrahydrocannabinol (THC), 0.3% to be precise, which makes it impossible for these products to create a high. What’s left is the purest form of CBD that can be used to make natural painkillers and even skin-care products that can fight problems like acne, wrinkles, and uneven skin tone.


Read more: ‘CBD: The Biotech Boom Investors Haven’t Woken Up To Yet’

Leave a Reply

Your email address will not be published.